Tau isoform regulation is region‐ and cell‐specific in mouse brain
- 29 October 2008
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 511 (6) , 788-803
- https://doi.org/10.1002/cne.21867
Abstract
Tau is a microtubule‐associated protein implicated in neurodegenerative tauopathies. Alternative splicing of the tau gene (MAPT) generates six tau isoforms, distinguishable by the exclusion or inclusion of a repeat region of exon 10, which are referred to as 3‐repeat (3R) and 4‐repeat (4R) tau, respectively. We developed transgenic mouse models that express the entire human MAPT gene in the presence and absence of the mouse Mapt gene and compared the expression and regulation of mouse and human tau isoforms during development and in the young adult. We found differences between mouse and human tau in the regulation of exon 10 inclusion. Despite these differences, the isoform splicing pattern seen in normal human brain is replicated in our mouse models. In addition, we found that all tau, both in the neonate and young adult, is phosphorylated. We also examined the normal anatomic distribution of mouse and human tau isoforms in mouse brain. We observed developmental and species‐specific variations in the expression of 3R‐ and 4R‐tau within the frontal cortex and hippocampus. In addition, there were differences in the cellular distribution of the isoforms. Mice transgenic for the human MAPT gene exhibited higher levels of neuronal cell body expression of tau compared to wildtype mice. This neuronal cell body expression of tau was limited to the 3R isoform, whereas expression of 4R‐tau was more “synaptic like,” with granular staining of neuropil rather than in neuronal cell bodies. These developmental and species‐specific differences in the regulation and distribution of tau isoforms may be important to the understanding of normal and pathologic tau isoform expression. J. Comp. Neurol. 511:788–803, 2008.Keywords
This publication has 90 references indexed in Scilit:
- Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's diseaseAnnals of Neurology, 2007
- Knock-out and transgenic mouse models of tauopathiesNeurobiology of Aging, 2007
- Modulation of Microtubule Dynamics by Tau in Living Cells: Implications for Development and NeurodegenerationMolecular Biology of the Cell, 2004
- The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodiesFEBS Letters, 2002
- Tau and transgenic animal modelsBrain Research Reviews, 2001
- Structural and Functional Differences between 3-Repeat and 4-Repeat Tau IsoformsJournal of Biological Chemistry, 2000
- Single-Step Conversion of P1 and P1 Artificial Chromosome Clones into Yeast Artificial ChromosomesGenomics, 2000
- Tau is a candidate gene for chromosome 17 frontotemporal dementiaAnnals of Neurology, 1998
- Genetic evidence for the involvement of τ in progressive supranuclear palsyAnnals of Neurology, 1997
- The microtubule binding domain of tau proteinNeuron, 1989